MXPA05013121A - Derivados de indol con efecto de induccion de apoptosis. - Google Patents
Derivados de indol con efecto de induccion de apoptosis.Info
- Publication number
- MXPA05013121A MXPA05013121A MXPA05013121A MXPA05013121A MXPA05013121A MX PA05013121 A MXPA05013121 A MX PA05013121A MX PA05013121 A MXPA05013121 A MX PA05013121A MX PA05013121 A MXPA05013121 A MX PA05013121A MX PA05013121 A MXPA05013121 A MX PA05013121A
- Authority
- MX
- Mexico
- Prior art keywords
- indole derivatives
- apoptosis
- inducing effect
- medicaments
- inducing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La invencion se refiere a derivados de indol usados como medicamentos para el tratamiento de enfermedades de tumor, de manera particular en el caso de resistencia de medicamentos contra otros ingredientes activos y carcinoma en metastasis.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47627703P | 2003-06-05 | 2003-06-05 | |
EP03012868A EP1484329A1 (de) | 2003-06-06 | 2003-06-06 | Indolderivate mit Apoptose induzierender Wirkung |
EP04011598A EP1595878A1 (de) | 2004-05-15 | 2004-05-15 | Indolderivate mit Apoptose induzierender Wirkung |
PCT/EP2004/005593 WO2004108702A1 (de) | 2003-06-05 | 2004-05-25 | Indolderivate mit apoptose induzierender wirkung |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05013121A true MXPA05013121A (es) | 2006-03-17 |
Family
ID=43661564
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05013121A MXPA05013121A (es) | 2003-06-05 | 2004-05-25 | Derivados de indol con efecto de induccion de apoptosis. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1641777A1 (es) |
JP (1) | JP4878285B2 (es) |
KR (1) | KR101132599B1 (es) |
CN (1) | CN1816543B (es) |
AU (1) | AU2004245198B2 (es) |
BR (1) | BRPI0410998A (es) |
CA (1) | CA2526663C (es) |
MX (1) | MXPA05013121A (es) |
NZ (1) | NZ543853A (es) |
RS (1) | RS20050901A (es) |
RU (1) | RU2327696C2 (es) |
WO (1) | WO2004108702A1 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1790342A1 (de) | 2005-11-11 | 2007-05-30 | Zentaris GmbH | Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege |
US8217042B2 (en) | 2005-11-11 | 2012-07-10 | Zentaris Gmbh | Pyridopyrazines and their use as modulators of kinases |
CA2628039A1 (en) * | 2005-11-11 | 2007-05-18 | Aeterna Zentaris Gmbh | Novel pyridopyrazines and their use as modulators of kinases |
AU2006318212C1 (en) * | 2005-11-23 | 2012-08-30 | The Board Of Regents Of The University Of Texas System | Oncogenic ras-specific cytotoxic compound and methods of use thereof |
JP5406716B2 (ja) * | 2006-08-07 | 2014-02-05 | アイアンウッド ファーマシューティカルズ インコーポレイテッド | インドール化合物 |
WO2008066807A1 (en) * | 2006-11-28 | 2008-06-05 | Ziopharm Oncology, Inc. | Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer |
BRPI0920878A2 (pt) * | 2008-10-16 | 2015-12-22 | Array Biopharma Inc | inbidor de ksp161 para aumentar apoptose, sua administração e seu uso. |
WO2012017325A2 (en) * | 2010-07-19 | 2012-02-09 | Procaps Sa | Apparatus and process for encapsulating microparticles with liquid in soft gel capsules |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19814838C2 (de) * | 1998-04-02 | 2001-01-18 | Asta Medica Ag | Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung |
TWI269654B (en) * | 1999-09-28 | 2007-01-01 | Baxter Healthcare Sa | N-substituted indole-3-glyoxylamide compounds having anti-tumor action |
DE19962300A1 (de) * | 1999-12-23 | 2001-06-28 | Asta Medica Ag | Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung |
IT1318641B1 (it) * | 2000-07-25 | 2003-08-27 | Novuspharma Spa | Ammidi di acidi 2-(1h-indol-3-il)-2-oxo-acetici ad attivita'antitumorale. |
DE10037310A1 (de) * | 2000-07-28 | 2002-02-07 | Asta Medica Ag | Neue Indolderivate und deren Verwendung als Arzneimittel |
JP2005504790A (ja) * | 2001-09-13 | 2005-02-17 | シンタ ファーマスーティカルズ コーポレイション | 癌を治療するための3−グリオキシリルアミドインドール |
-
2004
- 2004-05-25 WO PCT/EP2004/005593 patent/WO2004108702A1/de active Application Filing
- 2004-05-25 MX MXPA05013121A patent/MXPA05013121A/es active IP Right Grant
- 2004-05-25 EP EP04734662A patent/EP1641777A1/de not_active Withdrawn
- 2004-05-25 KR KR1020057023347A patent/KR101132599B1/ko not_active IP Right Cessation
- 2004-05-25 AU AU2004245198A patent/AU2004245198B2/en not_active Ceased
- 2004-05-25 NZ NZ543853A patent/NZ543853A/en not_active IP Right Cessation
- 2004-05-25 RU RU2006100022/04A patent/RU2327696C2/ru not_active IP Right Cessation
- 2004-05-25 BR BRPI0410998-8A patent/BRPI0410998A/pt not_active IP Right Cessation
- 2004-05-25 CN CN2004800192716A patent/CN1816543B/zh not_active Expired - Fee Related
- 2004-05-25 JP JP2006508197A patent/JP4878285B2/ja not_active Expired - Fee Related
- 2004-05-25 CA CA2526663A patent/CA2526663C/en not_active Expired - Fee Related
- 2004-05-25 RS YUP-2005/0901A patent/RS20050901A/sr unknown
Also Published As
Publication number | Publication date |
---|---|
CA2526663A1 (en) | 2004-12-16 |
NZ543853A (en) | 2009-09-25 |
RU2006100022A (ru) | 2006-05-27 |
JP2007523850A (ja) | 2007-08-23 |
CN1816543B (zh) | 2011-01-19 |
AU2004245198A1 (en) | 2004-12-16 |
KR101132599B1 (ko) | 2012-06-21 |
WO2004108702A1 (de) | 2004-12-16 |
AU2004245198B2 (en) | 2009-04-23 |
RU2327696C2 (ru) | 2008-06-27 |
BRPI0410998A (pt) | 2006-07-04 |
JP4878285B2 (ja) | 2012-02-15 |
RS20050901A (en) | 2007-12-31 |
KR20060034230A (ko) | 2006-04-21 |
CA2526663C (en) | 2011-07-19 |
EP1641777A1 (de) | 2006-04-05 |
CN1816543A (zh) | 2006-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY143795A (en) | Tetrahydropyridoindole derivatives | |
MX2009006704A (es) | Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa. | |
HK1096392A1 (en) | Substituted heterocycles | |
GEP20084520B (en) | Use of retinyl derivatives and compositions thereof for treating ophthalmic diseases | |
ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
WO2007127273A3 (en) | Methods and compositions for altering cell function | |
WO2007002836A3 (en) | Methods and compositions for the prevention and treatment of kidney disease | |
MXPA06012143A (es) | Arilsulfonamidas y usos relacionados con las mismas. | |
UA108878C2 (ru) | Ингибиторы протеинтирозинкиназной активности | |
EP1812112A4 (en) | CHEMICAL COMPOUNDS | |
ATE531703T1 (de) | Benzochromenderivate | |
MXPA04001256A (es) | Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso. | |
ZA201000581B (en) | 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives,preparation and therapeutic use thereof | |
ATE475651T1 (de) | Aryl-substituierte heterozyklen und ihre verwendung | |
RS20050901A (en) | Indole derivatives with apoptosis- inducing effect | |
DE502005005652D1 (de) | Heterocyclyl-substituierte nonadepsipeptide | |
MXPA05008902A (es) | Soluciones de drogas en mentol. | |
TW200504051A (en) | Novel acridine derivatives and their use as medicaments | |
JO2666B1 (en) | Use of agomelatine for medications to treat bilateral mental disorders | |
UA86021C2 (ru) | Производные индола с эффектом, который индуцирует апоптоз | |
WO2005018569A3 (en) | Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin modulating agent for the treatment of neoplasia | |
TW200603791A (en) | Compounds and compositions as cathepsin S inhibitors | |
IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases | |
MY150436A (en) | 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof | |
WO2007012066A3 (en) | TRUNCATED OXIDIZED THYMOSIN β4 AND DERIVATIVES THEREOF |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |